Xenon Pharmaceuticals Inc
XENE
Market Cap$2.98B
Close$
$1.72
95.6% downside
Current Fair Value
95.6% downsideOvervalued by 95.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.98 Billion |
|---|---|
| Enterprise Value | $2.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.01 |
| Beta | 1.17 |
| Outstanding Shares | 78,953,445 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.98 |
|---|---|
| PEG | -23.76 |
| Price to Sales | - |
| Price to Book Ratio | 4.85 |
| Enterprise Value to Revenue | 381.52 |
| Enterprise Value to EBIT | -8.99 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xenon Pharmaceuticals Inc
CEO: Simon Pimstone